UMIN-CTR Clinical Trial

Recruitment status Recruiting
Unique ID issued by UMIN UMIN000017868
Receipt No. R000020700
Official scientific title of the study A Validation Study of a Point-of-Care Nerve Conduction Device for the Prediction of Chemotherapy-induced Peripheral Neurotoxicity
Date of disclosure of the study information 2015/06/11
Last modified on 2016/12/11 (Ver. 4)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study A Validation Study of a Point-of-Care Nerve Conduction Device for the Prediction of Chemotherapy-induced Peripheral Neurotoxicity
Title of the study (Brief title) A Validation Study of a Point-of-Care Nerve Conduction Device for the Prediction of Chemotherapy-induced Peripheral Neurotoxicity
Region
Japan

Condition
Condition Those who have the possibility of developing chemotherapy-induced peripheral neurotoxicity
Classification by specialty
Medicine in general Hematology and clinical oncology Neurology
Adult
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 To evaluate the validity of a point-of-care nerve conduction device (NC-stat) for the prediction of chemotherapy-induced peripheral neurotoxicity
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1 Exploratory
Trial characteristics_2 Pragmatic
Developmental phase Not applicable

Assessment
Primary outcomes Comparison of the point-of-care nerve conduction studies of those who have the possibility of developing CIPN, with the time course and extent of CIPN of them
Key secondary outcomes Correlation of the quantitative assesment of CIPN through the point-of-care nerve conduction device (NC-stat) with the quantitative assesment of CIPN through NCI-CTCAE ver4.0

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Diagnosis
Type of intervention
Device,equipment
Interventions/Control_1 To measure the sural nerve sensory conduction verocity (SNCV) and sensory action potential (SNAP) by the point-of-care nerve conduction device (NC-stat) at each chemotherapy cycle
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Adult patients who are going to have chemotherapy including oxaliplatin, paclitaxel or docetaxel are included. All patients will have written informed consent.
Key exclusion criteria Patients with pre-existing neuropathy, such as diabetes mellitus, alcoholic abuse or central nervous system metastasis are excluded.
Target sample size 100

Research contact person
Name of lead principal investigator Yuichi Ando
Organization Nagoya University Hospital
Division name Department of Clinical Oncology and Chemotherapy
Address 65 Tsuruma-Cho, Showa-Ku, Nagoya, Japan
TEL 052-744-1903
Email yando@med.nagoya-u.ac.jp

Public contact
Name of contact person Ayumu Matsuoka
Organization Nagoya University Hospital
Division name Department of Clinical Oncology and Chemotherapy
Address 65 Tsuruma-Cho, Showa-Ku, Nagoya, Japan
TEL 052-744-1903
Homepage URL
Email ayumu0611@med.nagoya-u.ac.jp

Sponsor
Institute Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital
Institute
Department

Funding Source
Organization Management Expenses Grants
Organization
Division
Category of Funding Organization Japanese Governmental office
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s) Novartis Pharma K.K

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2015 Year 06 Month 11 Day

Progress
Recruitment status Recruiting
Date of protocol fixation
2015 Year 05 Month 27 Day
Anticipated trial start date
2015 Year 06 Month 27 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2015 Year 06 Month 10 Day
Last modified on
2016 Year 12 Month 11 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000020700